PRCT Q3 2025 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$83M+42.8% YoY

Gross Profit

$54M64.8% margin

Operating Income

-$23M-27.8% margin

Net Income

-$21M-25.7% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$10M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$512M

Total Liabilities

$131M

Stockholders' Equity

$380M

Cash & Equivalents

$294M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$58M	+42.8%
Gross Profit	$54M	$37M	+46.3%
Operating Income	-$23M	-$22M	-3.4%
Net Income	-$21M	-$21M	-2.1%

Geographic Segments

UNITED STATES

$74M89%

Outside the United States

$9M11%